Traditional Knowledge and Formulations of Medicinal Plants Used by the Traditional Medical Practitioners of Bangladesh to Treat Schizophrenia Like Psychosis

被引:25
作者
Ahmed, Md. Nasir [1 ]
Azam, Md. Nur Kabidul [1 ]
机构
[1] TechB Herbal Solut, Ethnobot & Ethnomed Div, Bheramara 7040, Kushtia, Bangladesh
关键词
D O I
10.1155/2014/679810
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Schizophrenia is a subtle disorder of brain development and plasticity; it affects the most basic human processes of perception, emotion, and judgment. In Bangladesh the traditional medical practitioners of rural and remote areas characterized the schizophrenia as an insanity or a mental problem due to possession by ghosts or evil spirits and they have used various plant species' to treat such symptoms. The aim of the present study was to conduct an ethnomedicinal plant survey and documentation of the formulations of different plant parts used by the traditional medical practitioners of Rangamati district of Bangladesh for the treatment of schizophrenia like psychosis. It was observed that the traditional medical practitioners used a total of 15 plant species to make 14 formulations. The plants were divided into 13 families, used for treatment of schizophrenia and accompanying symptoms like hallucination, depression, oversleeping or insomnia, deterioration of personal hygiene, forgetfulness, and fear due to evil spirits like genies or ghost. A search of the relevant scientific literatures showed that a number of plants used by the medicinal practitioners have been scientifically validated in their uses and traditional medicinal knowledge has been a means towards the discovery of many modern medicines. Moreover, the antipsychotic drug reserpine, isolated from the dried root of Rauvolfia serpentina species, revolutionized the treatment of schizophrenia. So it is very much possible that formulations of the practitioner, when examined scientifically in their entireties, can form discovery of lead compounds which can be used as safe and effective antipsychotic drug to treat schizophrenia.
引用
收藏
页数:10
相关论文
共 84 条
[1]   What have we learned from proton magnetic resonance spectroscopy about schizophrenia? A critical update [J].
Abbott, C ;
Bustillo, J .
CURRENT OPINION IN PSYCHIATRY, 2006, 19 (02) :135-139
[2]  
Addington J., 2004, PSYCHOL INTERVENTION, P99
[3]  
Adnaik R.S., 2009, INT J GREEN PHARM, V3, P243, DOI [10.4103/0973-8258.56284, DOI 10.4103/0973-8258.56284]
[4]  
Agarwal V., 2010, COCHRANE DB SYST REV, V3
[5]  
Ahmed M. N., 2013, P INT C UPD NATUR PR
[6]  
Alexiades MN., 1996, SELECTED GUIDELINES
[7]  
[Anonymous], 1996, GLOBAL BURDEN DIS CO
[8]   Neurodevelopment, neuroplasticity, and new genes for schizophrenia [J].
Arnold, SE ;
Talbot, K ;
Hahn, CG .
DEVELOPMENT, DYNAMICS AND PATHOLOGY OF NEURONAL NETWORKS: FROM MOLECULES TO FUNCTIONAL CIRCUITS, 2005, 147 :319-345
[9]  
Avinash D. S., 2013, J MED PLANTS STUDIES, V1, P18
[10]   Traditional knowledge of Kani tribals in Kouthalai of Tirunelveli hills, Tamil Nadu, India [J].
Ayyanar, M ;
Ignacimuthu, S .
JOURNAL OF ETHNOPHARMACOLOGY, 2005, 102 (02) :246-255